<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">VDI</journal-id>
<journal-id journal-id-type="hwp">spvdi</journal-id>
<journal-title>Journal of Veterinary Diagnostic Investigation</journal-title>
<issn pub-type="ppub">1040-6387</issn>
<issn pub-type="epub">XXXX-XXXX</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1040638712471059</article-id>
<article-id pub-id-type="publisher-id">10.1177_1040638712471059</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pathologic and immunophenotypic characterization of 26 camelid malignant round cell tumors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Aboellail</surname><given-names>Tawfik A.</given-names></name>
<xref ref-type="corresp" rid="corresp1-1040638712471059">1</xref>
</contrib>
<aff id="aff1-1040638712471059">Veterinary Diagnostic Laboratories, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1040638712471059"><label>1</label>Tawfik A. Aboellail, Veterinary Diagnostic Laboratories, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, 300 W. Drake Street, Fort Collins, CO 80523. <email>Tawfik.aboellail@colostate.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>25</volume>
<issue>1</issue>
<fpage>168</fpage>
<lpage>172</lpage>
<permissions>
<copyright-statement>© 2013 The Author(s)</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">American Association of Veterinary Laboratory Diagnosticians</copyright-holder>
</permissions>
<abstract>
<p>Lymphoma and/or leukemia was diagnosed in 26 camelids (20 alpacas and 6 llamas) out of 110 camelid neoplasia archived January 1995 through January 2012 at the Colorado State Veterinary Diagnostic Laboratories (CSU-VDL). Some of the tumors presented a diagnostic challenge because they could not be distinguished on the basis of gross or microscopic morphology. Immunohistochemistry using a T-cell marker (cluster of differentiation [CD]3), a B-cell marker (paired box protein [PAX]-5), a leukocyte integrin beta-2 marker (CD18), and a neuroendocrine marker (synaptophysin) was employed to help differentiate between lymphoma and other malignant round cell tumors. Alpaca lymphomas presented as either juvenile disseminated lymphoma in crias ≤2 years of age (<italic>n</italic> = 8) or adult multicentric lymphoma and/or leukemia (<italic>n</italic> = 12). Lymphomas in alpacas were of T-cell origin (<italic>n</italic> = 13), non–B-cell, non–T-cell origin (<italic>n</italic> = 4), B-cell origin (<italic>n</italic> = 2), or myelogenous leukemia (<italic>n</italic> = 1). Abdominal organs, predominantly the liver, were commonly involved in both the crias and adult alpacas. Lymphomas in llamas presented as either adult multicentric lymphoma of B-cell origin in animals younger than 7 years of age (<italic>n</italic> = 2), or T-cell lymphoma (<italic>n</italic> = 2), and non–B-cell, non–T-cell lymphoma (<italic>n</italic> = 1) in animals 7 years of age or older. The thorax was commonly involved in llamas, with infiltration of neoplastic cells into hilar and mediastinal lymph nodes. A rare type of lymphoma diagnosed in the llamas was cutaneous, epitheliotrophic T-cell lymphoma (<italic>n</italic> = 1).</p>
</abstract>
<kwd-group>
<kwd>Alpacas</kwd>
<kwd>B cell</kwd>
<kwd>cutaneous</kwd>
<kwd>disseminate</kwd>
<kwd>epitheliotrophic</kwd>
<kwd>llamas</kwd>
<kwd>leukemia</kwd>
<kwd>lymphoma</kwd>
<kwd>non–B-cell, non–T-cell</kwd>
<kwd>round cell</kwd>
<kwd>T cell</kwd>
<kwd>tumor</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Lymphoma has been reported to be the most common neoplasia in camelids from different parts of the world.<sup><xref ref-type="bibr" rid="bibr1-1040638712471059">1</xref>,<xref ref-type="bibr" rid="bibr8-1040638712471059">8</xref>,<xref ref-type="bibr" rid="bibr13-1040638712471059">13</xref></sup> Studies revealed that there was a significant difference in the age of alpacas (range: 0.2–2 years, median: 0.8 years) and llamas (range: 0.3–15 years, median: 5.5 years) diagnosed with lymphoma.<sup><xref ref-type="bibr" rid="bibr9-1040638712471059">9</xref>,<xref ref-type="bibr" rid="bibr13-1040638712471059">13</xref></sup> Immunohistochemical characterization of lymphomas has been undertaken in small numbers of camelids.<sup><xref ref-type="bibr" rid="bibr1-1040638712471059">1</xref>,<xref ref-type="bibr" rid="bibr7-1040638712471059">7</xref>,<xref ref-type="bibr" rid="bibr13-1040638712471059">13</xref></sup> Analysis of greater numbers of round cell tumors is still needed to better investigate any relationship between immunophenotype, age, sex, organ distribution, and clinical or pathological diagnosis. The purpose of the current study is to report the pathologic and immunophenotypic characteristics of lymphoma and/or leukemia in alpacas and llamas archived January 1995 through January 2012 at Colorado State University Veterinary Diagnostic Laboratory (CSU-VDL; Fort Collins, Colorado).</p>
<p>Immunohistochemical staining was performed on an automated staining platform<sup><xref ref-type="fn" rid="fn1-1040638712471059">a</xref></sup> using an alkaline phosphatase red kit<sup><xref ref-type="fn" rid="fn2-1040638712471059">b</xref></sup> as chromogen. Primary antibodies and methods of antigen retrieval are listed in <xref ref-type="table" rid="table1-1040638712471059">Table 1</xref>. Species distribution, age, and sex of affected animals; organ involvement; and immunohistochemical characteristics of the archived tumors are summarized in <xref ref-type="table" rid="table2-1040638712471059">Table 2</xref>.</p>
<table-wrap id="table1-1040638712471059" position="float">
<label>Table 1.</label>
<caption><p>Sources of immunohistochemistry primary antibodies and antigen retrieval methods used in malignant round cell tumor diagnosis.</p></caption>
<graphic alternate-form-of="table1-1040638712471059" xlink:href="10.1177_1040638712471059-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Primary antibody (clone)</th>
<th align="center">Antigen retrieval</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mouse anti-canine CD18 (CA16.3C10)<sup><xref ref-type="fn" rid="fn3-1040638712471059">c</xref></sup></td>
<td>Protease I<sup><xref ref-type="fn" rid="fn4-1040638712471059">d</xref></sup></td>
</tr>
<tr>
<td>Rabbit anti-CD3 (A0452)<sup><xref ref-type="fn" rid="fn5-1040638712471059">e</xref></sup></td>
<td>Citrate pH 6.0<sup><xref ref-type="fn" rid="fn6-1040638712471059">f</xref></sup></td>
</tr>
<tr>
<td>Mouse anti-CD79a (HM47/A9)<sup><xref ref-type="fn" rid="fn7-1040638712471059">g</xref></sup></td>
<td>Citrate pH 6.0</td>
</tr>
<tr>
<td>Mouse B-cell–specific activator protein PAX-5 (BC/24)<sup><xref ref-type="fn" rid="fn8-1040638712471059">h</xref></sup></td>
<td>Citrate pH 6.0, EDTA<sup><xref ref-type="fn" rid="fn7-1040638712471059">g</xref></sup></td>
</tr>
<tr>
<td>Rabbit anti-synaptophysin (336A)<sup><xref ref-type="fn" rid="fn8-1040638712471059">h</xref></sup></td>
<td>Citrate pH 6.0</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="table2-1040638712471059" position="float">
<label>Table 2.</label>
<caption><p>Species, age, and sex of affected animals and summary of pathologic and immunophenotypic characteristics of malignant round cell tumors (lymphoma) diagnosed in alpacas and llamas submitted to Colorado State University Veterinary Diagnostic Laboratory (Fort Collins, Colorado) from 1995 to 2012.<xref ref-type="table-fn" rid="table-fn1-1040638712471059">*</xref></p></caption>
<graphic alternate-form-of="table2-1040638712471059" xlink:href="10.1177_1040638712471059-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th/>
<th/>
<th align="center" colspan="4">Intensity of immunoreactivity<hr/></th>
<th/>
</tr>
<tr>
<th align="left">Species/No.</th>
<th align="center">Sex</th>
<th align="center">Age</th>
<th align="center">Subtype/anatomic location</th>
<th align="center">CD3</th>
<th align="center">PAX-5</th>
<th align="center">CD18</th>
<th align="center">Synaptophysin</th>
<th align="center">Diagnosis</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="9">Juvenile disseminated</td>
</tr>
<tr>
<td colspan="9">Alpaca</td>
</tr>
<tr>
<td> 1</td>
<td>F</td>
<td>&lt;1m</td>
<td>Liver<xref ref-type="table-fn" rid="table-fn2-1040638712471059">†</xref></td>
<td>+++</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td> 2</td>
<td>M</td>
<td>4 m</td>
<td>Liver, spleen, kidneys, LNs, bone marrow</td>
<td>+++</td>
<td>++</td>
<td>ND</td>
<td>ND</td>
<td>B-cell rich, T-cell lymphoma</td>
</tr>
<tr>
<td> 3</td>
<td>F</td>
<td>5 m</td>
<td>Liver, spleen, kidneys, LNs, bone marrow</td>
<td>+++</td>
<td>++</td>
<td>ND</td>
<td>ND</td>
<td>B-cell rich, T-cell lymphoma</td>
</tr>
<tr>
<td> 4</td>
<td>F</td>
<td>11 m</td>
<td>Liver, spleen, kidneys, lungs, pancreas</td>
<td>+</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>Non-B, non-T lymphoma</td>
</tr>
<tr>
<td> 5</td>
<td>M</td>
<td>12 m</td>
<td>Liver, kidney, heart</td>
<td>++++</td>
<td>−</td>
<td>ND</td>
<td>ND</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td> 6</td>
<td>M</td>
<td>16 m</td>
<td>Liver, kidneys, lungs, abdominal mass</td>
<td>+++</td>
<td>−</td>
<td>ND</td>
<td>−</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td> 7</td>
<td>F</td>
<td>24 m</td>
<td>Liver, lung arteries, caudal abdominal mass</td>
<td>+++</td>
<td>−</td>
<td>ND</td>
<td>ND</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td> 8</td>
<td>F</td>
<td>24 m</td>
<td>Prescapular LN<xref ref-type="table-fn" rid="table-fn2-1040638712471059">†</xref></td>
<td>++++</td>
<td>−</td>
<td>ND</td>
<td>ND</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td align="center" colspan="9">Adult multicentric</td>
</tr>
<tr>
<td colspan="9">Alpaca</td>
</tr>
<tr>
<td> 9</td>
<td>F</td>
<td>25 m</td>
<td>Liver, spleen, LNs</td>
<td>+</td>
<td>++++</td>
<td>ND</td>
<td>ND</td>
<td>B-cell lymphoma</td>
</tr>
<tr>
<td> 10</td>
<td>F</td>
<td>3 y</td>
<td>Liver, spleen</td>
<td>++</td>
<td>+++</td>
<td>ND</td>
<td>ND</td>
<td>Leukemic T-cell rich, B-cell lymphoma</td>
</tr>
<tr>
<td> 11</td>
<td>F</td>
<td>4 y</td>
<td>Liver, lungs, gastric chamber 1 (C1)</td>
<td>+</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>Non-B, non-T lymphoma</td>
</tr>
<tr>
<td> 12</td>
<td>M</td>
<td>4 y</td>
<td>Liver, spleen, lungs, LNs</td>
<td>++</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td> 13</td>
<td>F</td>
<td>6 y</td>
<td>Liver, skeletal muscles of hind limb, sacrolumbar spinal cord</td>
<td>+++</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td> 14</td>
<td>M</td>
<td>6 y</td>
<td>Spleen, mesentery, LNs, lungs</td>
<td>+</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>Non-B, non-T lymphoma</td>
</tr>
<tr>
<td> 15</td>
<td>F</td>
<td>8 y</td>
<td>Spleen, intestine, LNs, myocardium, kidneys</td>
<td>++++</td>
<td>−</td>
<td>ND</td>
<td>ND</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td> 16</td>
<td>F</td>
<td>12 y</td>
<td>Liver, spleen intestine, mesenteric LNs</td>
<td>+</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>Non-B, non-T lymphoma</td>
</tr>
<tr>
<td> 17</td>
<td>F</td>
<td>14 y</td>
<td>Liver, lungs, kidneys, mediastinal LNs</td>
<td>++++</td>
<td>−</td>
<td>ND</td>
<td>ND</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td> 18</td>
<td>CM</td>
<td>14 y</td>
<td>Liver, cervical LNs, intestine</td>
<td>+</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>Non-B, non-T lymphoma</td>
</tr>
<tr>
<td> 19</td>
<td>F</td>
<td>U</td>
<td>Liver<xref ref-type="table-fn" rid="table-fn2-1040638712471059">†</xref></td>
<td>++</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td> 20</td>
<td>F</td>
<td>U</td>
<td>Liver, spleen, LNs, bone marrow</td>
<td>+</td>
<td>−</td>
<td>+++</td>
<td>−</td>
<td>Myeloid leukemia</td>
</tr>
<tr>
<td colspan="9">Llama</td>
</tr>
<tr>
<td> 21</td>
<td>CM</td>
<td>3 y</td>
<td>Trachea, kidney</td>
<td>−</td>
<td>+++</td>
<td>−</td>
<td>ND</td>
<td>B-cell lymphoma</td>
</tr>
<tr>
<td> 22</td>
<td>F</td>
<td>5 y</td>
<td>Liver, lungs, kidneys</td>
<td>+</td>
<td>+++</td>
<td>−</td>
<td>−</td>
<td>B-cell lymphoma</td>
</tr>
<tr>
<td> 23</td>
<td>F</td>
<td>7 y</td>
<td>Heart base, pericardium, hilar LNs, lungs, C1</td>
<td>+/−</td>
<td>−</td>
<td>−</td>
<td>−</td>
<td>Non-B, non-T lymphoma</td>
</tr>
<tr>
<td> 24</td>
<td>F</td>
<td>7 y</td>
<td>Mediastinum, lungs, LNs, mammary gland, bone marrow</td>
<td>++++</td>
<td>−</td>
<td>ND</td>
<td>ND</td>
<td>T-cell lymphoma</td>
</tr>
<tr>
<td> 25</td>
<td>CM</td>
<td>21 y</td>
<td>Mediastinal LNs, abdominal mass</td>
<td>+++</td>
<td>++</td>
<td>ND</td>
<td>−</td>
<td>B-cell rich T-cell lymphoma</td>
</tr>
<tr>
<td align="center" colspan="9">Cutaneous</td>
</tr>
<tr>
<td colspan="9">Llama</td>
</tr>
<tr>
<td> 26</td>
<td>F</td>
<td>20 y</td>
<td>Eyelid subcutis</td>
<td>++++</td>
<td>−</td>
<td>ND</td>
<td>ND</td>
<td>T-cell lymphoma</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1040638712471059">
<label>*</label>
<p>CM = castrated male; F = female; m = month(s); y = year(s); U = unknown age; LNs = lymph nodes; ND = not determined; ++++ = strongly positive; +++ = moderately positive; ++ = slightly positive; + = a few scattered cells are positive; +/– = suspicious; – = negative.</p>
</fn>
<fn id="table-fn2-1040638712471059">
<label>†</label>
<p>Biopsy or necropsy tissue from only 1 organ was submitted for histologic examination, but multicentricity was implied in the history.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Malignant round cell tumors are restricted in the present study to typical lymphoma, leukemic lymphoma, myeloid leukemia, and lymphoblastic non–B-cell, non–T-cell lymphoma (<italic>n</italic> = 26, 20 alpacas and 6 llamas), all of which were the most common neoplasias (out of a total of 110) diagnosed at CSU-VDL between 1995 and 2012. Lymphoma and leukemia had an overall prevalence of 22.2% and 23.6%, respectively, of camelid neoplasia if proliferative lesions are to be excluded. Alpaca lymphomas (77%) are overrepresented in the current study, which is consistent with previous reports.<sup><xref ref-type="bibr" rid="bibr9-1040638712471059">9</xref>,<xref ref-type="bibr" rid="bibr13-1040638712471059">13</xref>,<xref ref-type="bibr" rid="bibr15-1040638712471059">15</xref></sup> Statistical analyses revealed a clear predisposition of female camelids (total number of 76 females and 41 males from both species) to develop neoplastic/proliferative lesions (one-sided <italic>P</italic> = 0.0006) while female predisposition to develop lymphomas was not that highly significant (one-sided <italic>P</italic> = 0.0577).</p>
<p>Juvenile lymphomas in alpacas 2 years of age or younger (range: 0.1–2 years, median: 0.9 year) represented 40% of the alpaca lymphomas. The disseminated nature of juvenile lymphoma of T-cell origin and the wide variety of tissues involved suggests that the syndrome has many parallels with juvenile or calf lymphoma.<sup><xref ref-type="bibr" rid="bibr3-1040638712471059">3</xref>,<xref ref-type="bibr" rid="bibr4-1040638712471059">4</xref></sup> Affected alpacas had bilateral peripheral lymphadenopathy, often marked abdominal organomegaly, and occasional leukemic profile (neoplastic cells in vascular spaces) with bone marrow involvement in 25% of the cases (the percentage could have been higher if affected animals had been submitted in whole for necropsy rather than sending just 1 organ for histologic evaluation). True thymic involvement, however, was not detected in any of the CSU-VDL cases, but the base of the heart was involved in 1 case.</p>
<p>Cells from a lymphoma in the lung of an 11-month-old alpaca stained neither for T-cell nor B-cell markers (<xref ref-type="fig" rid="fig1-1040638712471059">Fig. 1</xref>), which suggests the possibility of non–B-cell, non–T-cell origin (lymphoblasts), given that camelids in prior studies developed these lymphoblastic tumors very early in neonatal life or even perinatally.<sup><xref ref-type="bibr" rid="bibr4-1040638712471059">4</xref>,<xref ref-type="bibr" rid="bibr7-1040638712471059">7</xref>,<xref ref-type="bibr" rid="bibr9-1040638712471059">9</xref>,<xref ref-type="bibr" rid="bibr10-1040638712471059">10</xref></sup> In human beings, non–B, non–T cells with lymphoblast morphology are classified into 4 categories: 1) cluster of differentiation (CD)7+ stem cell lymphoma, 2) blastic natural killer lymphoma (B-NKL), 3) myeloid/NK precursor cell leukemia (M/NKL), and 4) CD4+CD56+ hematodermic malignancy.<sup><xref ref-type="bibr" rid="bibr6-1040638712471059">6</xref></sup> The adult alpaca multicentric lymphomas described herein (<xref ref-type="fig" rid="fig2-1040638712471059">Fig. 2</xref>) were very similar to the disseminated forms described in the literature.<sup><xref ref-type="bibr" rid="bibr1-1040638712471059">1</xref>,<xref ref-type="bibr" rid="bibr5-1040638712471059">5</xref>,<xref ref-type="bibr" rid="bibr7-1040638712471059">7</xref>,<xref ref-type="bibr" rid="bibr13-1040638712471059">13</xref></sup> Acute myeloid leukemia with multilineage dysplasia, previously diagnosed at CSU-DVL, was reported to occur in an 18-year-old female alpaca (not included in the current study because the tissue blocks could not be retrieved) and is somewhat similar to the case reported herein.<sup><xref ref-type="bibr" rid="bibr12-1040638712471059">12</xref></sup></p>
<fig id="fig1-1040638712471059" position="float">
<label>Figure 1.</label>
<caption><p>Eleven-month-old alpaca; lung; non–B-cell, non–T-cell lymphoma. Neoplastic cells show negative immunoreactivity against cluster of differentiation (CD)3, which only stains rare mature lymphocytes interspersed among neoplastic cells. Bar = 100 µm.</p></caption>
<graphic xlink:href="10.1177_1040638712471059-fig1.tif"/>
</fig>
<fig id="fig2-1040638712471059" position="float">
<label>Figure 2.</label>
<caption><p>Three-year-old alpaca; liver; leukemic T-cell, B-cell rich lymphoma. Immature lymphocytes diffusely fill hepatic sinusoids and replace and dissect hepatic plates. Bar = 100 µm.</p></caption>
<graphic xlink:href="10.1177_1040638712471059-fig2.tif"/>
</fig>
<p>Lymphomas in llamas in the current study occurred at an older age than alpacas, with only adult animals (range: 3–21 years, median 7 years) affected. The multicentric adult lymphoma in the llamas showed more predilection for the thorax, with rare involvement of respiratory organs, particularly trachea, a finding corroborated by other studies.<sup><xref ref-type="bibr" rid="bibr2-1040638712471059">2</xref>,<xref ref-type="bibr" rid="bibr7-1040638712471059">7</xref>,<xref ref-type="bibr" rid="bibr14-1040638712471059">14</xref></sup> The lymphomas were B-cell lymphomas (40%), T-cell lymphomas (40%), and non–B-cell, non–T-cell lymphomas (20%).</p>
<p>In both species, liver was the most commonly involved parenchymatous organ (<xref ref-type="fig" rid="fig2-1040638712471059">Figs. 2</xref>, <xref ref-type="fig" rid="fig3-1040638712471059">3A</xref>), followed by the spleen, peripheral and visceral lymph nodes, kidneys, and lungs. Involvement of myocardium (<xref ref-type="fig" rid="fig3-1040638712471059">Fig. 3B</xref>), pancreas, and gastric chamber 1 (C1; <xref ref-type="fig" rid="fig3-1040638712471059">Fig. 3C</xref>) was evident in 1 alpaca, and spinal cord and skeletal muscles of the hind limb was identified in only 1 llama.</p>
<fig id="fig3-1040638712471059" position="float">
<label>Figure 3.</label>
<caption><p>Immunohistochemistry. <bold>A</bold>, alpaca; liver; &lt;30 days old; multifocal and coalescing aggregates of neoplastic cells show strong immunoreactivity against paired box protein (PAX)-5, replacing approximately 85% of the hepatic parenchyma of a less than 30-day-old alpaca. Bar = 100 µm. <bold>B</bold>, alpaca; heart; 1-year-old; the myocardium of 1-year-old alpaca is largely obliterated by cluster of differentiation (CD)3-positive immature lymphocytes. Bar = 100 µm. <bold>C</bold>, alpaca; small intestine; 8-year-old; variably eroded small intestine is markedly expanded by a diffuse infiltrate of CD3-positive immature lymphocytes throughout the mucosa with multifocal involvement of the submucosa. Bar = 100 µm. <bold>D</bold>, llama; eye lid; 20-year-old; arrows indicate multifocal intraepidermal infiltrates “Pautrier abscesses” of CD3-positive cells that diffusely infiltrate the underlying dermis in a 20-year-old llama. Bar = 100 µm.</p></caption>
<graphic xlink:href="10.1177_1040638712471059-fig3.tif"/>
</fig>
<p>Epitheliotrophic cutaneous lymphoma of T-cell origin in the eyelid of an aged llama was observed in the current study. The tumor is similar to “mycosis fungoides-like” disease in human beings and dogs, with formation of typical “Pautrier abscesses” (<xref ref-type="fig" rid="fig3-1040638712471059">Fig. 3D</xref>).<sup><xref ref-type="bibr" rid="bibr3-1040638712471059">3</xref></sup> Subcutaneous lymphomas reported to occur in alpacas in a previous study were not typed and did not show epidermal tropism.<sup><xref ref-type="bibr" rid="bibr11-1040638712471059">11</xref></sup> Prior studies confirmed the lack of retroviral etiology via electron microscopic studies.<sup><xref ref-type="bibr" rid="bibr1-1040638712471059">1</xref>,<xref ref-type="bibr" rid="bibr9-1040638712471059">9</xref></sup></p>
<p>The current study summarizes the pathologic and immunophenotypic characteristics of 26 camelid lymphomas. The clinical disease and postmortem findings in 20 alpacas and 6 llamas can be broadly categorized into 2 syndromes in each species: T-cell juvenile disseminate (40%) and adult multicentric lymphomas in alpacas (60%) and adult multicentric (83%) and epitheliotrophic (17%) lymphomas in llamas. Further classification of camelid lymphoma and/or leukemia, especially the lymphoblast non–B-cell, non–T-cell lymphomas, merits further studies using human markers, namely, CD7, B-NKL, M/NKL, and CD4+CD56+, to better characterize these tumors.</p>
</body>
<back>
<ack>
<p>The author would like to thank Todd Bass and Bruce Cummings for their technical help and invaluable expertise in immunohistochemistry and Alexandra Harvey for assistance with archived tissue retrieval.</p>
</ack>
<fn-group>
<title>Sources and manufacturers</title>
<fn fn-type="other" id="fn1-1040638712471059">
<label>a.</label>
<p>Benchmark Immunostainer, Ventana Medical Systems Inc., Tucson, AZ.</p>
</fn>
<fn fn-type="other" id="fn2-1040638712471059">
<label>b.</label>
<p>UltraView Alkaline Phosphatase Red Kit, Ventana Medical Systems Inc., Tucson, AZ.</p>
</fn>
<fn fn-type="other" id="fn3-1040638712471059">
<label>c.</label>
<p>Leukocyte Antigen Biology Laboratory, Davis, CA.</p>
</fn>
<fn fn-type="other" id="fn4-1040638712471059">
<label>d.</label>
<p>Protease I, Ventana Medical Systems Inc., Tucson, AZ.</p>
</fn>
<fn fn-type="other" id="fn5-1040638712471059">
<label>e.</label>
<p>Dako North America Inc., Carpinteria, CA.</p>
</fn>
<fn fn-type="other" id="fn6-1040638712471059">
<label>f.</label>
<p>Target Retrieval Solution (pH 6.0), Dako North America Inc., Carpinteria, CA.</p>
</fn>
<fn fn-type="other" id="fn7-1040638712471059">
<label>g.</label>
<p>BioCare Medical, Concord, CA.</p>
</fn>
<fn fn-type="other" id="fn8-1040638712471059">
<label>h.</label>
<p>Ventana Medical Systems Inc., Tucson, AZ.</p>
</fn>
<fn fn-type="conflict">
<label>Declaration of conflicting interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) declared that they received no financial support for their research and/or authorship of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1040638712471059">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cebra</surname><given-names>CK</given-names></name>
<name><surname>Garry</surname><given-names>FB</given-names></name>
<name><surname>Powers</surname><given-names>BE</given-names></name>
<name><surname>Johnson</surname><given-names>LW</given-names></name>
</person-group>: <year>1995</year>, <article-title>Lymphosarcoma in 10 New World camelids</article-title>. <source>J Vet Intern Med</source> <volume>9</volume>:<fpage>381</fpage>–<lpage>385</lpage>.</citation>
</ref>
<ref id="bibr2-1040638712471059">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fowler</surname><given-names>ME</given-names></name>
<name><surname>Gillespie</surname><given-names>D</given-names></name>
<name><surname>Harkema</surname><given-names>J</given-names></name>
</person-group>: <year>1985</year>, <article-title>Lymphosarcoma in a llama</article-title>. <source>J Am Vet Med Assoc</source> <volume>187</volume>:<fpage>1245</fpage>–<lpage>1246</lpage>.</citation>
</ref>
<ref id="bibr3-1040638712471059">
<label>3.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Goldscmidt</surname><given-names>MH</given-names></name>
<name><surname>Hendrick</surname><given-names>MJ</given-names></name>
</person-group>: <year>2002</year>, <article-title>Tumors of skin of the soft tissues</article-title>. <italic>In</italic>: <source>Tumors in domestic animals</source>, ed. <person-group person-group-type="editor">
<name><surname>Meuten</surname><given-names>DJ</given-names></name>
</person-group>, <edition>4th ed</edition>., pp. <fpage>88</fpage>–<lpage>89</lpage>, <fpage>114</fpage>–<lpage>115</lpage>. <publisher-name>Iowa State Press</publisher-name>, <publisher-loc>Ames, IA</publisher-loc>.</citation>
</ref>
<ref id="bibr4-1040638712471059">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hemsley</surname><given-names>S</given-names></name>
<name><surname>Bailey</surname><given-names>G</given-names></name>
<name><surname>Canfield</surname><given-names>P</given-names></name>
</person-group>: <year>2002</year>, <article-title>Immunohistochemical characterization of lymphosarcoma in two alpacas (<italic>Lama pacos</italic>)</article-title>. <source>J Comp Pathol</source> <volume>127</volume>:<fpage>69</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr5-1040638712471059">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Irwin</surname><given-names>JA</given-names></name>
</person-group>: <year>2001</year>, <article-title>Lymphosarcoma in an alpaca</article-title>. <source>Can Vet J</source> <volume>42</volume>:<fpage>805</fpage>–<lpage>806</lpage>.</citation>
</ref>
<ref id="bibr6-1040638712471059">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaurbe</surname><given-names>K</given-names></name>
<name><surname>Ohshima</surname><given-names>K</given-names></name>
<name><surname>Tuschiya</surname><given-names>T</given-names></name>
<etal/>
</person-group>.: <year>2003</year>, <article-title>Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification</article-title>. <source>Am J Surg Pathol</source> <volume>27</volume>:<fpage>1366</fpage>–<lpage>1374</lpage>.</citation>
</ref>
<ref id="bibr7-1040638712471059">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martin</surname><given-names>JM</given-names></name>
<name><surname>Valentine</surname><given-names>BA</given-names></name>
<name><surname>Cebra</surname><given-names>CK</given-names></name>
<etal/>
</person-group>.: <year>2009</year>, <article-title>Malignant round cell neoplasia in llamas and alpacas</article-title>. <source>Vet Pathol</source> <volume>46</volume>:<fpage>288</fpage>–<lpage>298</lpage>.</citation>
</ref>
<ref id="bibr8-1040638712471059">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martin</surname><given-names>JM</given-names></name>
<name><surname>Valentine</surname><given-names>BA</given-names></name>
<name><surname>Cebra</surname><given-names>CK</given-names></name>
</person-group>: <year>2010</year>, <article-title>Clinical, ultrasonographic, and laboratory findings in 12 llamas and 12 alpacas with malignant round cell neoplasia</article-title>. <source>Can Vet J</source> <volume>51</volume>:<fpage>1379</fpage>–<lpage>1382</lpage>.</citation>
</ref>
<ref id="bibr9-1040638712471059">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pusterla</surname><given-names>N</given-names></name>
<name><surname>Colgrove</surname><given-names>KM</given-names></name>
<name><surname>Moore</surname><given-names>PF</given-names></name>
<etal/>
</person-group>.: <year>2006</year>, <article-title>Multicentric T-cell lymphosarcoma in an alpaca</article-title>. <source>Vet J</source> <volume>171</volume>:<fpage>181</fpage>–<lpage>185</lpage>.</citation>
</ref>
<ref id="bibr10-1040638712471059">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sartin</surname><given-names>EA</given-names></name>
<name><surname>Crowe</surname><given-names>DR</given-names></name>
<name><surname>Whitley</surname><given-names>EM</given-names></name>
<etal/>
</person-group>.: <year>2004</year>, <article-title>Malignant neoplasia in four alpacas</article-title>. <source>J Vet Diagn Invest</source> <volume>16</volume>:<fpage>226</fpage>–<lpage>229</lpage>.</citation>
</ref>
<ref id="bibr11-1040638712471059">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scott</surname><given-names>DW</given-names></name>
<name><surname>Vogel</surname><given-names>JW</given-names></name>
<name><surname>Fleis</surname><given-names>RI</given-names></name>
<etal/>
</person-group>.: <year>2011</year>, <article-title>Skin diseases in the alpaca (<italic>Vicugna pacos</italic>): a literature review and retrospective analysis of 68 cases (Cornell University 1997–2006)</article-title>. <source>Vet Dermatol</source> <volume>22</volume>:<fpage>2</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr12-1040638712471059">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Steinberg</surname><given-names>JD</given-names></name>
<name><surname>Olver</surname><given-names>CS</given-names></name>
<name><surname>Davis</surname><given-names>WC</given-names></name>
<etal/>
</person-group>.: <year>2008</year>, <article-title>Acute myeloid leukemia with multilineage dysplasia in an alpaca</article-title>. <source>Vet Clin Pathol</source> <volume>37</volume>:<fpage>289</fpage>–<lpage>297</lpage>.</citation>
</ref>
<ref id="bibr13-1040638712471059">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Twomey</surname><given-names>DF</given-names></name>
<name><surname>Barlow</surname><given-names>AM</given-names></name>
<name><surname>Hemsley</surname><given-names>S</given-names></name>
</person-group>: <year>2008</year>, <article-title>Immunophenotyping of lymphosarcoma in South American camelids on six British premises</article-title>. <source>Vet J</source> <volume>175</volume>:<fpage>133</fpage>–<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr14-1040638712471059">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Underwood</surname><given-names>WJ</given-names></name>
<name><surname>Bell</surname><given-names>TG</given-names></name>
</person-group>: <year>1993</year>, <article-title>Multicentric lymphosarcoma in a llama</article-title>. <source>J Vet Diagn Invest</source> <volume>5</volume>:<fpage>117</fpage>–<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr15-1040638712471059">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Valentine</surname><given-names>BA</given-names></name>
<name><surname>Martin</surname><given-names>JM</given-names></name>
</person-group>: <year>2007</year>, <article-title>Prevalence of neoplasia in llamas and alpacas (Oregon State University, 2001–2006)</article-title>. <source>J Vet Diagn Invest</source> <volume>19</volume>:<fpage>202</fpage>–<lpage>204</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>